https://link.springer.com/article/10.1007/s40259-024-00644-7?error=cookies_not_supported&code=9fabd11b-f161-44c8-9fa8-c8d7adfc4363
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases |...
Jan 22, 2024 - The last decade (2013–2023) has seen unprecedented successes in the clinical translation of therapeutic antisense oligonucleotides (ASOs). Eight such
antisense oligonucleotidessplicetherapeuticsinheritedmetabolic
https://profiles.wustl.edu/en/publications/age-dependent-effects-of-apoe-reduction-using-antisense-oligonucl/fingerprints/?sortBy=alphabetically
Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of...
https://oligotherapeutics.org/comparison-of-the-class-effects-of-antisense-oligonucleotides-in-cbyb6f1-tghras2jic-and-cd-1-mice/
Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice...
Aug 3, 2021 - Kim TW, Papagiannis CN, Zwick LS, Engelhardt JA, Hoffmaster CM, Post NM, Matson JE, Hsiao JA, Burel SA, Henry SP. Toxicol Pathol. 2018 Dec 25:192623318813143....
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Induction-of-cryptic-pre-mRNA-splice-switching-by/991005541274407891
Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides - Murdoch University
Antisense oligomers (AOs) are increasingly being used to modulate RNA splicing in live cells, both for research and for the development of therapeutics. While...